Skip to content

motor endplate

Physiology/Neuromuscular PharmacologyMusculoskeletalNervous System

Summary

The motor endplate is the specialized postsynaptic region of a skeletal muscle fiber at the neuromuscular junction (NMJ), where the motor neuron's axon terminal releases acetylcholine (ACh) to trigger muscle contraction. It contains a high density of nicotinic ACh receptors clustered in junctional folds. This structure is the key target of many diseases and drugs affecting neuromuscular transmission.

Detail

The motor endplate is the postsynaptic specialization of the skeletal muscle fiber membrane (sarcolemma) at the neuromuscular junction. Physiology: An action potential in the motor neuron triggers voltage-gated Ca2+ channel opening at the presynaptic terminal, causing ACh vesicle fusion and release into the synaptic cleft. ACh diffuses across and binds nicotinic ACh receptors (ligand-gated cation channels) densely packed on the folds of the motor endplate. This causes Na+ influx, generating an endplate potential (EPP), which if threshold is reached, triggers a muscle action potential via adjacent voltage-gated Na+ channels, leading to excitation-contraction coupling (via T-tubules, DHPR-RyR interaction, Ca2+ release from sarcoplasmic reticulum, and actin-myosin crossbridge cycling). Acetylcholinesterase (AChE) in the synaptic cleft rapidly degrades ACh to terminate the signal.

Clinical significance: - Myasthenia gravis: autoantibodies against postsynaptic nicotinic ACh receptors reduce EPP amplitude, causing fatigable weakness; improves with anticholinesterase drugs. - Lambert-Eaton myasthenic syndrome: autoantibodies against presynaptic voltage-gated Ca2+ channels reduce ACh release; weakness improves with repeated use (unlike MG). - Botulinum toxin: cleaves SNARE proteins, blocking ACh vesicle release, causing flaccid paralysis. - Organophosphate poisoning: inhibits AChE, causing excess ACh accumulation (cholinergic crisis). - Neuromuscular blocking drugs: succinylcholine (depolarizing blocker) and nondepolarizing agents (e.g., rocuronium, vecuronium) act at the nicotinic receptors of the motor endplate to induce paralysis for anesthesia.

Histology: The motor endplate has a specialized architecture with junctional folds that increase surface area for ACh receptors, and it sits opposite the presynaptic terminal separated by the synaptic cleft, forming the tripartite neuromuscular junction (nerve terminal, synaptic cleft, motor endplate).

Sources

  • Kaplan USMLE Step 1 Physiology
  • First Aid for the USMLE Step 1
  • Guyton and Hall Textbook of Medical Physiology
  • Katzung's Basic and Clinical Pharmacology

Reviewed by AnkiBoss editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.